1.21
-0.01(-0.82%)
Currency In USD
| Previous Close | 1.22 |
| Open | 1.22 |
| Day High | 1.24 |
| Day Low | 1.19 |
| 52-Week High | 2.72 |
| 52-Week Low | 0.85 |
| Volume | 4.7M |
| Average Volume | 7.34M |
| Market Cap | 363.45M |
| PE | -0.54 |
| EPS | -2.23 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 1.4 |
| Change | -0.01 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $328.8 as of September 29, 2025 at a share price of $1.21. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $123.47 as of September 29, 2025 at a share price of $1.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
GlobeNewswire Inc.
Sep 22, 2025 1:05 PM GMT
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screeningMENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highl
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
GlobeNewswire Inc.
Sep 03, 2025 1:05 PM GMT
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancerMENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PA
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models
GlobeNewswire Inc.
Aug 04, 2025 1:05 PM GMT
The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based toolsMENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accu